During a 2024 India Today Conclave session, Tech Today editor Aayush Ailawadi interviewed Moran Cerf, a neuroscientist, Israeli security specialist, and professor at Columbia Business School. Cerf made a thought-provoking claim, suggesting that Elon Musk's Neuralink technology might be vital in curing cancer.
Discussing Musk's Neuralink, which recently achieved its first human brain implant, Cerf elaborated: "The essence of Neuralink is that our brain is the same brain from many millennia, and there are some limitations to what this brain can do. We have a harder time dealing with the world around us, and the question is, can we enhance the brain by essentially creating a digital component that will interface with that?"
